Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Friday, 10th May 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0701 $0.104
52 weeks $0.0600 $0.85

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Sep 16, 2016 $19.65 $20.02 $19.40 $19.87 688 600
Sep 15, 2016 $19.19 $19.85 $19.01 $19.75 245 200
Sep 14, 2016 $18.41 $19.20 $18.41 $19.11 276 400
Sep 13, 2016 $18.37 $18.75 $17.88 $18.27 158 100
Sep 12, 2016 $17.75 $18.77 $17.51 $18.75 263 800
Sep 09, 2016 $18.30 $18.60 $17.83 $17.86 220 200
Sep 08, 2016 $18.19 $18.84 $17.75 $18.69 259 100
Sep 07, 2016 $17.87 $18.55 $17.78 $18.51 282 300
Sep 06, 2016 $17.32 $17.95 $17.32 $17.85 233 800
Sep 02, 2016 $17.49 $17.60 $17.06 $17.24 180 000
Sep 01, 2016 $17.18 $17.47 $17.03 $17.47 138 300
Aug 31, 2016 $17.53 $17.66 $17.02 $17.22 186 200
Aug 30, 2016 $17.29 $17.75 $17.19 $17.61 198 500
Aug 29, 2016 $17.47 $17.60 $17.10 $17.33 131 000
Aug 26, 2016 $17.07 $17.43 $16.83 $17.32 241 000
Aug 25, 2016 $17.20 $17.87 $16.57 $17.03 303 100
Aug 24, 2016 $18.64 $19.20 $16.87 $17.19 353 700
Aug 23, 2016 $18.82 $19.36 $18.58 $18.61 273 200
Aug 22, 2016 $18.65 $19.46 $18.23 $18.65 508 800
Aug 19, 2016 $18.30 $18.81 $18.06 $18.12 294 400
Aug 18, 2016 $18.88 $18.90 $18.30 $18.45 391 700
Aug 17, 2016 $19.76 $19.94 $18.76 $18.84 397 200
Aug 16, 2016 $19.07 $19.95 $19.04 $19.72 354 400
Aug 15, 2016 $19.75 $20.08 $18.95 $19.18 412 300
Aug 12, 2016 $19.64 $19.95 $19.39 $19.89 268 000
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT